Literature DB >> 16101535

Pathways of T cell activation and terminal differentiation in chronic inflammation.

Pia Isomäki1, Joanna M Clark, Manvinder Panesar, Andrew P Cope.   

Abstract

Immune and inflammatory responses are governed by antigen-specific T cells, whose activation, differentiation and effector function are induced by signals delivered via the T cell antigen receptor (TCR) and by costimulatory and cytokine receptors. The molecular events leading to the activation of naïve T cells have been extensively studied and are well characterized. Much less is known about the molecular and biochemical events regulating the activation of T cells in chronic inflammatory diseases such as rheumatoid arthritis (RA). This review examines the current state of knowledge of T cell activation in chronic inflammation, focusing on RA, and summarizes experimental data which indicate that the chronic inflammatory process may profoundly affect TCR and cytokine signal transduction pathways. We present evidence suggesting that in chronic inflammation, the antigen-driven TCR-mediated processes are attenuated, while cytokine-driven effector responses are sustained or even enhanced. The possible implications of this inbalance are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101535     DOI: 10.2174/1568010054022042

Source DB:  PubMed          Journal:  Curr Drug Targets Inflamm Allergy        ISSN: 1568-010X


  8 in total

1.  Activation of p38 mitogen-activated protein kinase is critical step for acquisition of effector function in cytokine-activated T cells, but acts as a negative regulator in T cells activated through the T-cell receptor.

Authors:  Ching Li; Paul Beavis; Andrew C Palfreeman; Parisa Amjadi; Alan Kennedy; Fionula M Brennan
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

Review 2.  Biocompatibility of implants: lymphocyte/macrophage interactions.

Authors:  James M Anderson; Amy K McNally
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

3.  Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions.

Authors:  M Guadalupe Cabral; Marília Pereira; Zélia Silva; Inês Iria; Carla Coutinho; Andreia Lopes; Isabel Sá-Correia; Paula A Videira
Journal:  Med Microbiol Immunol       Date:  2016-12-16       Impact factor: 3.402

4.  Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus.

Authors:  L Ma; P Zhao; Z Jiang; Y Shan; Y Jiang
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

5.  Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.

Authors:  Xiujun Pan; Xiangliang Yuan; Yingxia Zheng; Weiwei Wang; Jianping Shan; Fujun Lin; Gengru Jiang; Yuan H Yang; Die Wang; Dakang Xu; Lisong Shen
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

6.  Targeted in vitro and in vivo gene transfer into T lymphocytes: potential of direct inhibition of allo-immune activation.

Authors:  Ashwani K Khanna; Mandeep R Mehra
Journal:  BMC Immunol       Date:  2006-11-10       Impact factor: 3.615

7.  The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.

Authors:  Thi A Tran; Melissa K McCoy; Michael B Sporn; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2008-05-12       Impact factor: 8.322

8.  Characterization of murine macrophages from bone marrow, spleen and peritoneum.

Authors:  Changqi Wang; Xiao Yu; Qi Cao; Ya Wang; Guoping Zheng; Thian Kui Tan; Hong Zhao; Ye Zhao; Yiping Wang; David Ch Harris
Journal:  BMC Immunol       Date:  2013-02-05       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.